Low prevalence of Factor V Leiden and the prothrombin G20210A mutation in a healthy population from the central-south region of Chile

Palomo, Iván; Segovia, Fabian; Parra, Daniela; Alarcón, Marcelo; Rojas, Edgardo.
Rev. bras. hematol. hemoter ; 31(3): 143-146, 2009.
Artículo en Inglés | LILACS | ID: lil-523133

Documentos relacionados

  1. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank.
  2. Successful Digital Revascularization in a Patient With Factor V Leiden Mutation.
  3. Making sense of FV short.
  4. The Etiology of the Thrombotic Phenomena Involved in the Process of Coronary Artery Disease-What Is the Role of Thrombophilic Genes in the Development of This Pathology?
  5. Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.
  6. Association of Factor V Leiden G1691A and Prothrombin gene G20210A mutations with adverse pregnancy outcomes.
  7. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
  8. Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.
  9. Full-scale network analysis reveals properties of the FV protein structure organization.
  10. Cryo-EM structure of coagulation factor V short.